Cencora Inc. (COR)

Cencora, Inc. (NYSE:COR ) Wells Fargo 20th Annual Healthcare Conference 2025 September 5, 2025 8:45 AM EDT Company Participants James Cleary - Executive VP & CFO Bennett Murphy - Senior VP, Head of In...

COR gains from strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose risks.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Investors with an interest in Medical Services stocks have likely encountered both Cencora (COR) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?

The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. GE, HWM, COR and CAKE are some such stocks.

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has appointed Lead Independent Director D. Mark Durcan as Chairman of the Board of Directors, ...

Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.

Here is how Climb Bio, Inc. (CLYM) and Cencora (COR) have performed compared to their sector so far this year.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Cencora delivered strong quarterly results and guidance upgrades, but expectations need to be moderated as these results should fade in the coming quarters. The valuation remains elevated at 17.9x for...